ArticleCancer research communications2026
A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers.
Marwan Fakih et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.